Molecularly Imprinted Polymer Nanoparticles for Reducing Herpes Simplex Virus Type 2 Infection

Area of Science:

• Nanomedicine
• Virology
• Materials Science

Background:

• Herpes simplex virus type 2 (HSV-2) is a significant public health concern.
• Developing effective antiviral strategies for HSV-2 remains a challenge.
• Selective targeting of viral pathogens is crucial for developing novel therapeutics.

Purpose of the Study:

• To synthesize and characterize molecularly imprinted polymer nanoparticles (nanoMIPs) for selective HSV-2 recognition.
• To evaluate the antiviral efficacy and mechanism of action of nanoMIPs against HSV-2.
• To assess the biocompatibility and stability of nanoMIPs under various conditions.

Main Methods:

• Solid-phase imprinting was used to synthesize nanoMIPs.
• NanoMIPs were characterized for size, morphology, and binding affinity using electrochemical methods.
• Antiviral activity was assessed through infection inhibition assays.
• Cytotoxicity and stability studies were performed.

Main Results:

• Synthesized nanoMIPs were spherical (146 nm) and demonstrated enhanced binding to HSV-2.
• NanoMIPs showed high selectivity for HSV-2 over other viruses.
• Significant reduction in HSV-2 infection was observed (up to 80% inhibition).
• NanoMIPs exhibited excellent biocompatibility and stability under extreme pH and sterilization conditions.

Conclusions:

• NanoMIPs act as effective biomimetic receptors for selective HSV-2 recognition and inhibition.
• The mechanism involves direct binding to viral particles, blocking host cell attachment.
• NanoMIPs represent a promising, stable, and robust platform for antiviral nanomedicine and HSV-2 prevention.